Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(10 sites)
United States
University of Miami, Miami, Florida Northwestern Medicine (Data collection and specimen analysis), Chicago, Illinois Dana Farber Cancer Institute, Boston, Massachusetts Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey Memorial Sloan Kettering Commack, Commack, New York Memorial Sloan Kettering Westchester, Harrison, New York Memorial Sloan Kettering Cancer Center, New York, New York Weill Cornell Medical College, New York, New York Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale, New York Age range
18 Years and older
Last updated February 2026